Sao Tome and Principe Tech: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sao Tome and Principe Tech.

Press releases published on November 9, 2026

an hour ago

FlowX.AI & Google Take Mission-Critical AI Agents From Pilot to Production

Indeterminate GlobeNewswire

an hour ago

Zealand Pharma to participate in the Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

an hour ago

Kyverna Therapeutics Announces Publication of Registrational Miv-cel Data in Patients with Stiff Person Syndrome in JAMA Neurology

Indeterminate GlobeNewswire

an hour ago

Gumtree Group Runs Continuous Pentesting Across Its Marketplaces with Synack365

Indeterminate GlobeNewswire

2 hours ago

Loom Security Recognized as a CRN® 2026 Stellar Startup

Indeterminate GlobeNewswire

2 hours ago

From Writing Code to Running Agents: WeAreDevelopers Unveils the Program for Its First Conference in India

Indeterminate GlobeNewswire

2 hours ago

Hinge Bio Shares Encouraging Clinical Data for HB2198, a Novel B-Cell Depleting Agent for Treating Autoimmune Disease, at ACR Convergence 2026

Indeterminate GlobeNewswire

2 hours ago

Reach Security Recognized as a CRN® 2026 Stellar Startup

Indeterminate GlobeNewswire

2 hours ago

Software Safety Institute Launches to Reduce Preventable Harm from Insecure Software

Indeterminate GlobeNewswire

2 hours ago

Cullinan Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

2 hours ago

Kraig Labs Ships Spider Silk to Developers Across Global Industries

Indeterminate GlobeNewswire

2 hours ago

CloudTalk launches a new AI Sales Dialer for even more live conversations: Customers report going from 15 to 100+ calls per agent per day

Indeterminate GlobeNewswire

3 hours ago

Boehringer Ingelheim's survodutide is the first glucagon/GLP-1 dual agonist to demonstrate a favorable cardiovascular safety profile in global Phase III SYNCHRONIZE-CVOT trial alongside significant cardiometabolic benefits

Indeterminate GlobeNewswire

3 hours ago

Zealand Pharma announces Boehringer Ingelheim’s survodutide is the first glucagon/GLP-1 dual agonist to demonstrate a favorable cardiovascular safety profile in global Phase 3 SYNCHRONIZE-CVOT trial with significant cardiometabolic benefits

Indeterminate GlobeNewswire

3 hours ago

Oncovita Granted Orphan Drug Designation For MVdeltaC in Mesothelioma by the European Commission

Indeterminate GlobeNewswire

3 hours ago

From Fax Machines to Floppy Disks: Fisher Space Pen Celebrates 60 Years of the Pressurized Ink Cartridge That Outlasted Tech Giants

Indeterminate GlobeNewswire

3 hours ago

Qlik Appoints Anna Sharkey as Chief People Officer

Indeterminate GlobeNewswire

3 hours ago

SolidUltra secures €3 million to address AI data centers’ 800VDC power challenge

Indeterminate GlobeNewswire

3 hours ago

Pelareorep Induces Coordinated Antiviral Immune Responses and Enhanced Antitumor Immunity in Multiple Myeloma Patients

Indeterminate GlobeNewswire

3 hours ago

New Pacific AI Governor Capability Updates Healthcare AI Risk Assessments Whenever Laws or Systems Change

Indeterminate GlobeNewswire